Literature DB >> 29744347

Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease.

Luigi Elio Adinolfi1, Aldo Marrone1, Luca Rinaldi1.   

Abstract

Entities:  

Year:  2018        PMID： 29744347      PMCID： PMC5934122          DOI： 10.21037/hbsn.2018.02.01

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.

Authors:  P Loria; L E Adinolfi; S Bellentani; E Bugianesi; A Grieco; S Fargion; A Gasbarrini; C Loguercio; A Lonardo; G Marchesini; F Marra; M Persico; D Prati; G Svegliati- Baroni
Journal:  Dig Liver Dis       Date:  2010-02-19       Impact factor: 4.088

Review 2.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

Authors:  Siddharth Singh; Alina M Allen; Zhen Wang; Larry J Prokop; Mohammad H Murad; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

Review 3.  Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.

Authors:  Christina N Katsagoni; Michael Georgoulis; George V Papatheodoridis; Demosthenes B Panagiotakos; Meropi D Kontogianni
Journal:  Metabolism       Date:  2016-12-16       Impact factor: 8.694

4.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

5.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  J Hepatol       Date:  2016-04-07       Impact factor: 25.083

6.  Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Authors:  Jérôme Boursier; Julien Vergniol; Anne Guillet; Jean-Baptiste Hiriart; Adrien Lannes; Brigitte Le Bail; Sophie Michalak; Faiza Chermak; Sandrine Bertrais; Juliette Foucher; Frédéric Oberti; Maude Charbonnier; Isabelle Fouchard-Hubert; Marie-Christine Rousselet; Paul Calès; Victor de Lédinghen
Journal:  J Hepatol       Date:  2016-05-02       Impact factor: 25.083

Review 7.  A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?

Authors:  Ebenezer T Oni; Arthur S Agatston; Michael J Blaha; Jonathan Fialkow; Ricardo Cury; Andrei Sposito; Raimund Erbel; Ron Blankstein; Ted Feldman; Mouaz H Al-Mallah; Raul D Santos; Matthew J Budoff; Khurram Nasir
Journal:  Atherosclerosis       Date:  2013-08-09       Impact factor: 5.162

Review 8.  Exercise and ectopic fat in type 2 diabetes: A systematic review and meta-analysis.

Authors:  A Sabag; K L Way; S E Keating; R N Sultana; H T O'Connor; M K Baker; V H Chuter; J George; N A Johnson
Journal:  Diabetes Metab       Date:  2017-02-02       Impact factor: 6.041

9.  Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study.

Authors:  Fabio Piscaglia; Gianluca Svegliati-Baroni; Andrea Barchetti; Anna Pecorelli; Sara Marinelli; Claudio Tiribelli; Stefano Bellentani
Journal:  Hepatology       Date:  2016-01-14       Impact factor: 17.425

Review 10.  Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation.

Authors:  Elizabeth M Brunt
Journal:  Int J Mol Sci       Date:  2016-01-13       Impact factor: 5.923
View more
  5 in total

1.  Increased circulating cytokine levels in African American women with obesity and elevated HbA1c.

Authors:  Ariel Williams; Natasha Greene; K Kimbro
Journal:  Cytokine       Date:  2020-01-28       Impact factor: 3.861

Review 2.  Portal pressure monitoring-state-of-the-art and future perspective.

Authors:  Gang Xu; Fei Li; Yilei Mao
Journal:  Ann Transl Med       Date:  2019-10

Review 3.  Impaired albumin function: a novel potential indicator for liver function damage?

Authors:  Lejia Sun; Huanhuan Yin; Meixi Liu; Gang Xu; Xiaoxiang Zhou; Penglei Ge; Huayu Yang; Yilei Mao
Journal:  Ann Med       Date:  2019-11-21       Impact factor: 4.709

4.  Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.

Authors:  Shahar Azar; Shiran Udi; Adi Drori; Rivka Hadar; Alina Nemirovski; Kiran V Vemuri; Maya Miller; Dana Sherill-Rofe; Yhara Arad; Devorah Gur-Wahnon; Xiaoling Li; Alexandros Makriyannis; Danny Ben-Zvi; Yuval Tabach; Iddo Z Ben-Dov; Joseph Tam
Journal:  Mol Metab       Date:  2020-09-26       Impact factor: 7.422

5.  Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms.

Authors:  Marwa O El-Derany; Sherihan G AbdelHamid
Journal:  Life (Basel)       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.